VIVOBIOTBiotechnology
Vivo Bio Tech Ltd — Cash Flow Statement
₹21.05
+0.00%
Vivo Bio Tech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -10.44 Cr | 7.88 Cr | 10.84 Cr | -34.47 Cr | — |
| Issuance Of Capital Stock | 16.22 Cr | 0.00 | 2.10 Cr | 2.40 Cr | — |
| Capital Expenditure | -22.27 Cr | -7.95 Cr | -4.00 Cr | -51.11 Cr | — |
| End Cash Position | 1.21 Cr | 1.32 Cr | 1.37 Cr | 1.71 Cr | — |
| Beginning Cash Position | 1.32 Cr | 0.99 Cr | 1.71 Cr | 1.17 Cr | — |
| Changes In Cash | -0.11 Cr | 0.32 Cr | -0.34 Cr | 0.55 Cr | — |
| Financing Cash Flow | 3.90 Cr | -7.56 Cr | -11.18 Cr | 35.02 Cr | — |
| Net Other Financing Charges | 1000.00 | — | — | — | — |
| Interest Paid Cff | -5.47 Cr | -6.25 Cr | -6.28 Cr | -2.81 Cr | — |
| Net Common Stock Issuance | 16.22 Cr | 0.00 | 2.10 Cr | 2.40 Cr | — |
| Common Stock Issuance | 16.22 Cr | 0.00 | 2.10 Cr | 2.40 Cr | — |
| Net Issuance Payments Of Debt | -6.85 Cr | -1.30 Cr | -6.99 Cr | 35.43 Cr | — |
| Net Long Term Debt Issuance | -6.85 Cr | -1.30 Cr | -6.99 Cr | 35.43 Cr | — |
| Investing Cash Flow | -15.84 Cr | -7.95 Cr | -4.00 Cr | -51.11 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -15.84 Cr | -7.95 Cr | -4.00 Cr | -51.11 Cr | — |
| Sale Of PPE | 6.43 Cr | 0.00 | — | — | — |
| Purchase Of PPE | -22.27 Cr | -7.95 Cr | -4.00 Cr | -51.11 Cr | — |
| Operating Cash Flow | 11.83 Cr | 15.83 Cr | 14.83 Cr | 16.64 Cr | — |
| Taxes Refund Paid | -2.08 Cr | -1.68 Cr | -1.97 Cr | -2.27 Cr | — |
| Interest Paid Cfo | -2.04 Cr | -1.52 Cr | -1.37 Cr | -1.18 Cr | — |
| Change In Working Capital | -5.04 Cr | -2.09 Cr | -3.37 Cr | 4.18 Cr | — |
| Change In Payable | -9.89 Cr | 12.92 Cr | 2.79 Cr | 2.93 Cr | — |
| Change In Receivables | 4.85 Cr | -15.01 Cr | -6.15 Cr | 1.25 Cr | — |
| Other Non Cash Items | 2.94 Cr | 7.94 Cr | 7.65 Cr | 3.99 Cr | — |
| Depreciation And Amortization | 8.96 Cr | 9.13 Cr | 9.27 Cr | 7.45 Cr | — |
| Depreciation | 8.96 Cr | 9.13 Cr | 9.27 Cr | 7.45 Cr | — |
| Net Income From Continuing Operations | 9.08 Cr | 4.05 Cr | 4.62 Cr | 4.47 Cr | — |
| Repayment Of Debt | — | -1.30 Cr | -6.99 Cr | — | — |
| Long Term Debt Payments | — | -1.30 Cr | -6.99 Cr | — | — |
| Issuance Of Debt | — | — | — | 35.43 Cr | 4.96 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | — | 1000.00 | — |
| Long Term Debt Issuance | — | — | — | 35.43 Cr | 4.96 Cr |
| Purchase Of Investment | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vivo Bio Tech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.